Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Atrasentan is a selective antagonist of the endothelin-A (ETA) receptor and binds selectively to the ETA receptor, which may result in inhibition of endothelin-induced angiogenesis and tumor cell proliferation.